EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY-NC 4.0

Comment on the Article “Prognostic Usefulness of Clinical Complete Response after PD-1 Inhibitor-Based Combination Therapy for Unresectable Hepatocellular Carcinoma”

Mulin Liu, Qin Zheng, Juan Fu

Liver Cancer · 06.04.2026 · 1-2

DOI: 10.1159/000551853 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Liver Cancer, online erschienen am 06.04.2026. Verfasst von Mulin Liu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, First Affiliated Hospital of Dalian Medical University, Dalian, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 4 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Clinical complete responseDNA methylationHepatocellular carcinomaImmunotherapySpatial transcriptomicsTumor microenvironment

Autor:innen und Institutionen

  • Department of Clinical Laboratory, First Affiliated Hospital of Dalian Medical University, Dalian, China.
  • Department of Biochemistry and Molecular Biology, Dalian Medical University, Dalian, China.
  • Department of Obstetrics and Gynecology, First Affiliated Hospital of Dalian Medical University, Dalian, China.

Zitieren

APA

Liu, M., Zheng, Q., & Fu, J. (2026). Comment on the Article “Prognostic Usefulness of Clinical Complete Response after PD-1 Inhibitor-Based Combination Therapy for Unresectable Hepatocellular Carcinoma”. Liver Cancer, 1-2. https://doi.org/10.1159/000551853

Vancouver

Liu M, Zheng Q, Fu J. Comment on the Article “Prognostic Usefulness of Clinical Complete Response after PD-1 Inhibitor-Based Combination Therapy for Unresectable Hepatocellular Carcinoma”. Liver Cancer. 2026:1-2. doi:10.1159/000551853

BibTeX
@article{Liu2026,
  author = {Liu, Mulin and Zheng, Qin and Fu, Juan},
  title = {Comment on the Article “Prognostic Usefulness of Clinical Complete Response after PD-1 Inhibitor-Based Combination Therapy for Unresectable Hepatocellular Carcinoma”},
  journal = {Liver Cancer},
  year = {2026},
  pages = {1--2},
  doi = {10.1159/000551853}
}
Kostenlos starten →